RxDoctor Payments DataLook up a doctor →

Ryan Scott, DPM

Foot & Ankle Surgery · Phoenix, AZNPI 1053554600

Payments from drug & device makers

$1,128,674in general payments, 2019–2025

Across 894 payments — averaging $1262.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$620K
  • International Life Sciences$294K
  • Medline Industries LP$128K
  • Anika Therapeutics, Inc.$56K
  • Parcus Medical, LLC$11K
  • Amniox Medical, Inc.$7K
  • plus $13K from 26 others
$6,939in research payments, 2019–2025

Across 8 payments — averaging $867.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biotissue Holdings Inc.$6K
  • Stryker$780

What the payments were for

  • Royalty or licence$482,06843%
  • Consulting fees$512,34345%
  • Speaking & faculty fees$32,3163%
  • Travel & lodging$77,9007%
  • Food & beverage$22,8952%
  • Gifts$460%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,128,674 in reported general payments places this provider in the 95th percentile of 291 foot & ankle surgery providers in Arizona.

See all foot & ankle surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$129,179
Medicare patients
260
Services billed
1,451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib52$1,305
Gabapentin55$872
Ondansetron Hcl114$815
Meloxicam100$629
Methylprednisolone81$615
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen75$525
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$446
Diclofenac Sodium13$353
Ibuprofen11$248
Pregabalin22$224
Tramadol Hcl22$87
Prednisone11$21

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →